[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
Authors: Boudewijn Van Der Sanden, Olivier Duchamp, Laurent Lamalle, Nathalie Just, Zhour Housni, Nicolas Guilbaud, Philippe Genne, Chantal Rémy.
INSERM 594 ; Oncodesign
Abstract: A common treatment of malignant glioma, in addition to radiotherapy is the administration of carmustine (BCNU) as a chemotherapeutic drug.
In the present study, in vitro and in vivo investigations were performed for a panel of glioma models regarding their chemosensitivity to BCNU treatment.